Correlation Between Johnson Johnson and ArriVent BioPharma,
Can any of the company-specific risk be diversified away by investing in both Johnson Johnson and ArriVent BioPharma, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Johnson Johnson and ArriVent BioPharma, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Johnson Johnson and ArriVent BioPharma, Common, you can compare the effects of market volatilities on Johnson Johnson and ArriVent BioPharma, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Johnson Johnson with a short position of ArriVent BioPharma,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Johnson Johnson and ArriVent BioPharma,.
Diversification Opportunities for Johnson Johnson and ArriVent BioPharma,
-0.42 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Johnson and ArriVent is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Johnson Johnson and ArriVent BioPharma, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ArriVent BioPharma, and Johnson Johnson is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Johnson Johnson are associated (or correlated) with ArriVent BioPharma,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ArriVent BioPharma, has no effect on the direction of Johnson Johnson i.e., Johnson Johnson and ArriVent BioPharma, go up and down completely randomly.
Pair Corralation between Johnson Johnson and ArriVent BioPharma,
Considering the 90-day investment horizon Johnson Johnson is expected to generate 0.18 times more return on investment than ArriVent BioPharma,. However, Johnson Johnson is 5.51 times less risky than ArriVent BioPharma,. It trades about -0.24 of its potential returns per unit of risk. ArriVent BioPharma, Common is currently generating about -0.15 per unit of risk. If you would invest 16,160 in Johnson Johnson on August 27, 2024 and sell it today you would lose (643.00) from holding Johnson Johnson or give up 3.98% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Johnson Johnson vs. ArriVent BioPharma, Common
Performance |
| Timeline |
| Johnson Johnson |
| ArriVent BioPharma, |
Johnson Johnson and ArriVent BioPharma, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Johnson Johnson and ArriVent BioPharma,
The main advantage of trading using opposite Johnson Johnson and ArriVent BioPharma, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Johnson Johnson position performs unexpectedly, ArriVent BioPharma, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ArriVent BioPharma, will offset losses from the drop in ArriVent BioPharma,'s long position.| Johnson Johnson vs. Capricor Therapeutics | Johnson Johnson vs. Soleno Therapeutics | Johnson Johnson vs. Bio Path Holdings | Johnson Johnson vs. Moleculin Biotech |
| ArriVent BioPharma, vs. Tesla Inc | ArriVent BioPharma, vs. Yuexiu Transport Infrastructure | ArriVent BioPharma, vs. Afya | ArriVent BioPharma, vs. Lindblad Expeditions Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |